ZA200907643B - Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof - Google Patents
Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereofInfo
- Publication number
- ZA200907643B ZA200907643B ZA2009/07643A ZA200907643A ZA200907643B ZA 200907643 B ZA200907643 B ZA 200907643B ZA 2009/07643 A ZA2009/07643 A ZA 2009/07643A ZA 200907643 A ZA200907643 A ZA 200907643A ZA 200907643 B ZA200907643 B ZA 200907643B
- Authority
- ZA
- South Africa
- Prior art keywords
- methylpyrrolidine
- preparing
- processes
- tartrate salts
- tartrate
- Prior art date
Links
- RGHPCLZJAFCTIK-YFKPBYRVSA-N (2s)-2-methylpyrrolidine Chemical compound C[C@H]1CCCN1 RGHPCLZJAFCTIK-YFKPBYRVSA-N 0.000 title 1
- RGHPCLZJAFCTIK-RXMQYKEDSA-N (R)-2-methylpyrrolidine Chemical compound C[C@@H]1CCCN1 RGHPCLZJAFCTIK-RXMQYKEDSA-N 0.000 title 1
- 150000003892 tartrate salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92735607P | 2007-05-03 | 2007-05-03 | |
| PCT/US2008/005702 WO2008137087A1 (en) | 2007-05-03 | 2008-05-02 | Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200907643B true ZA200907643B (en) | 2014-03-26 |
Family
ID=39688886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2009/07643A ZA200907643B (en) | 2007-05-03 | 2009-10-30 | Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2152669A1 (OSRAM) |
| JP (1) | JP5698887B2 (OSRAM) |
| KR (1) | KR20100017565A (OSRAM) |
| CN (1) | CN101679237A (OSRAM) |
| AU (1) | AU2008248168B2 (OSRAM) |
| BR (1) | BRPI0810330A2 (OSRAM) |
| CA (1) | CA2686033A1 (OSRAM) |
| EA (1) | EA019031B1 (OSRAM) |
| IL (1) | IL201627A (OSRAM) |
| MX (1) | MX2009011787A (OSRAM) |
| NZ (1) | NZ580948A (OSRAM) |
| UA (1) | UA99913C2 (OSRAM) |
| WO (1) | WO2008137087A1 (OSRAM) |
| ZA (1) | ZA200907643B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2658821C (en) | 2006-07-25 | 2014-10-21 | Cephalon, Inc. | Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors |
| US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
| EP2752406A1 (en) * | 2008-01-30 | 2014-07-09 | Cephalon, Inc. | Substituted pyridazine derivatives which have histamine H3 antagonist activity |
| HK1244789B (en) * | 2014-12-23 | 2019-12-06 | Cephalon, Inc. | Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives |
| AR116299A1 (es) * | 2018-09-07 | 2021-04-21 | Sanofi Sa | Sales de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxilato de metilo y proceso de preparación de las mismas |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3329974A1 (de) | 1983-08-19 | 1985-02-28 | Bayer Ag, 5090 Leverkusen | Herstellung von hydrierten nitrilkautschuken |
| DE3433392A1 (de) | 1984-09-12 | 1986-03-20 | Bayer Ag, 5090 Leverkusen | Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer |
| FR2714849B1 (fr) | 1994-01-13 | 1996-04-05 | Inst Francais Du Petrole | Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique. |
| DE4403479A1 (de) | 1994-02-04 | 1995-08-10 | Basf Ag | Verfahren zur Herstellung von Hydroxylammoniumsalzen |
| WO2004024707A2 (en) * | 2002-09-16 | 2004-03-25 | Abbott Laboratories | Process for preparing amine type substituted benzofurans |
| US7153889B2 (en) | 2002-11-12 | 2006-12-26 | Abbott Laboratories | Bicyclic-substituted amines as histamine-3 receptor ligands |
| CN100543050C (zh) | 2004-03-08 | 2009-09-23 | 独立行政法人科学技术振兴机构 | 高分子担载金属簇组合物 |
| US7145005B2 (en) | 2004-05-12 | 2006-12-05 | Abbott Laboratories | 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation |
| PL1755593T3 (pl) | 2004-06-02 | 2008-06-30 | Hoffmann La Roche | Pochodne naftalenu przydatne jako ligandy 3-receptora histaminowego |
| WO2006059778A1 (ja) | 2004-12-01 | 2006-06-08 | Banyu Pharmaceutical Co., Ltd. | 置換ピリドン誘導体 |
| EP1831173B1 (en) | 2004-12-17 | 2011-01-26 | Janssen Pharmaceutica NV | Tetrahydroisoquinoline compounds for treatment of cns disorders |
| CN101107231A (zh) | 2005-01-21 | 2008-01-16 | 先灵公司 | 用作组胺h3拮抗剂的咪唑和苯并咪唑衍生物 |
| EP1866293A1 (en) | 2005-03-31 | 2007-12-19 | UCB Pharma, S.A. | Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| GB0514812D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| US7943605B2 (en) | 2005-10-27 | 2011-05-17 | Ucb Pharma S.A. | Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| ATE525072T1 (de) | 2006-02-09 | 2011-10-15 | Athersys Inc | Pyrazole zur behandlung von adipositas und anderen zns-erkrankungen |
| WO2007099423A1 (en) | 2006-03-02 | 2007-09-07 | Pfizer Products Inc. | 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists |
| WO2007105053A2 (en) | 2006-03-13 | 2007-09-20 | Pfizer Products Inc. | Tetralines antagonists of the h-3 receptor |
| JP2009542673A (ja) | 2006-06-29 | 2009-12-03 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ヒスタミンｈ３−受容体関連障害の治療に有用なヒスタミンｈ３−受容体モジュレータ |
| CA2658821C (en) | 2006-07-25 | 2014-10-21 | Cephalon, Inc. | Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors |
-
2008
- 2008-05-02 EA EA200971019A patent/EA019031B1/ru not_active IP Right Cessation
- 2008-05-02 WO PCT/US2008/005702 patent/WO2008137087A1/en not_active Ceased
- 2008-05-02 CA CA002686033A patent/CA2686033A1/en not_active Abandoned
- 2008-05-02 UA UAA200912476A patent/UA99913C2/ru unknown
- 2008-05-02 JP JP2010507416A patent/JP5698887B2/ja not_active Expired - Fee Related
- 2008-05-02 CN CN200880021225A patent/CN101679237A/zh active Pending
- 2008-05-02 KR KR1020097025141A patent/KR20100017565A/ko not_active Ceased
- 2008-05-02 AU AU2008248168A patent/AU2008248168B2/en not_active Ceased
- 2008-05-02 MX MX2009011787A patent/MX2009011787A/es active IP Right Grant
- 2008-05-02 NZ NZ580948A patent/NZ580948A/en not_active IP Right Cessation
- 2008-05-02 BR BRPI0810330-5A2A patent/BRPI0810330A2/pt not_active IP Right Cessation
- 2008-05-02 EP EP08754205A patent/EP2152669A1/en not_active Withdrawn
-
2009
- 2009-10-19 IL IL201627A patent/IL201627A/en not_active IP Right Cessation
- 2009-10-30 ZA ZA2009/07643A patent/ZA200907643B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008248168B2 (en) | 2013-03-21 |
| EA019031B1 (ru) | 2013-12-30 |
| KR20100017565A (ko) | 2010-02-16 |
| CA2686033A1 (en) | 2008-11-13 |
| MX2009011787A (es) | 2009-11-13 |
| JP2010526142A (ja) | 2010-07-29 |
| WO2008137087A1 (en) | 2008-11-13 |
| BRPI0810330A2 (pt) | 2014-10-14 |
| IL201627A0 (en) | 2010-05-31 |
| CN101679237A (zh) | 2010-03-24 |
| AU2008248168A1 (en) | 2008-11-13 |
| JP5698887B2 (ja) | 2015-04-08 |
| EA200971019A1 (ru) | 2010-04-30 |
| IL201627A (en) | 2014-06-30 |
| NZ580948A (en) | 2011-04-29 |
| EP2152669A1 (en) | 2010-02-17 |
| UA99913C2 (ru) | 2012-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL205253A (en) | Processes for the preparation of tubolysines | |
| PL2142109T3 (pl) | Szablony chirurgiczne | |
| EP2046751A4 (en) | PROCESS FOR PRODUCING SOLIFENACIN AND ITS SALTS | |
| IL181607A0 (en) | Novel process for preparing montelukast and salts thereof | |
| IL212639A0 (en) | Piperazine salt and a process for the preparation thereof | |
| IL192713A0 (en) | Reversible printing table | |
| IL197004A0 (en) | Pure paliperidone and processes for preparing thereof | |
| IL201248A (en) | Polates are marked f 18 and methods for preparing them | |
| IL198284A0 (en) | Processes for preparing palonosetron salts | |
| ZA200808308B (en) | Process for preparing linezolid | |
| EP2175856A4 (en) | NOVEL PROCESS FOR THE PREPARATION OF HIGH-PURITY LEVOCETRIXIN AND ITS SALTS | |
| ZA200907643B (en) | Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof | |
| IL181485A0 (en) | Processes for preparing novel montelukast salts | |
| GB0702537D0 (en) | Treatment for excessive adiposity | |
| GB0713189D0 (en) | Amino acid derivatives | |
| AP2008004592A0 (en) | Process for preparing human GCSF | |
| PL2274303T3 (pl) | Sposoby otrzymywania sunitynibu i jego soli | |
| ZA201008188B (en) | Stable r(+)-lansoprazole amine salt and a process for preparing the same | |
| ZA201005306B (en) | 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use | |
| GB2455650B (en) | Vaccines for brucellosis | |
| GB0715712D0 (en) | Amino acid derivatives | |
| ZA201000802B (en) | Process for the preparation of alfuzosin hydrochloride | |
| ZA200906277B (en) | Processes for making zilpaterol and salts thereof | |
| SG10201405734UA (en) | Processes For Making Zilpaterol And Salts Thereof | |
| IL205752A0 (en) | Octahydroquinolizines for antidiabetic treatment |